TIBOLONE 2.5MG TAB Class: Estrogen and Progestin

TIBOLONE 2.5MG TAB Class: Estrogen and Progestin

TIBOLONE 2.5MG TAB Class: Estrogen and Progestin Combination(synthetic steroid hormone) Indications: Prevention of postmenopausal osteoporosis; symptomatic treatment of hot flushes and associated sweating resulting from menopause (surgical or natural); improvement of bone mineral density in patients with established postmenopausal osteoporosis Available dosage form in the hospital: TIBOLONE 2.5MG TAB Dosage: -Symptoms associated with menopause: Females: Oral: 2.5 mg once daily. Initiate ≥1 year after naturally occurring menopause, or immediately in women with surgical menopause or those being treated with gonadotropin releasing hormone (GnRH) analogues. Note: Use caution in women >60 years of age due to increased stroke risk -Switching from other hormone replacement therapy (HRT): If on sequential HRT, initiate tibolone 1 day after the completion of the current treatment cycle. If on continuous-combined HRT, may initiate tibolone therapy immediately. Note: A separate progestogen should not be added to tibolone. -Missed dose: If >12 hours has elapsed, skip dose and resume at next regularly scheduled time. -Osteoporosis prophylaxis in postmenopausal women (unlabeled use in some countries): Oral: 2.5 mg once daily (Bundred, 2012; Roux, 2002). Note: In women >60 years of age, an increased risk of stroke was reported when taking 1.25 mg daily (Cummings, 2008). Geriatric Refer to adult dosing. Use caution in women >60 years of age due to increased stroke risk. Renal Impairment: No dosage adjustment provided in manufacturer’s labeling; use with caution (may increase risk of fluid retention). Hepatic Impairment: Use is contraindicated in acute or chronic liver disease. Common side effect: Common side effects observed in clinical studies (occurring in 1-10% of the women using Livial) were: vaginal bleeding or spotting abdominal pain weight gain breast pain unnatural hair growth vaginal symptoms, such as discharge, itching, and Pregnancy Risk Factor: D (Adverse events have been observed in animal reproduction studies; use is contraindicated during pregnancy). .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us